Activities per year
Activities
- 30 results
Search results
-
APC resistance as a marker of the risk of VTE in users of oral contraceptives. Practical usefulness for industry and for clinicians
Jonathan Douxfils (Invited speaker)
26 May 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Jonathan Douxfils (Speaker) & Laure Morimont (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Design of reduced point charge models of proteins - Applications to the CD2/CD58 protein complex
Laurence Leherte (Invited speaker)
3 Jul 2017Activity: Talk or presentation types › Invited talk
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Jonathan Douxfils (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Jonathan Douxfils (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Jonathan Douxfils (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
How to Measure Lupus Anticoagulants During DOAC Treatment?
Jonathan Douxfils (Speaker)
12 Jul 2020Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Jonathan Douxfils (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Intrinsic Flexibility of the μ Opioid Receptor through Multiscale Modelling Approaches - COMP403
Daniel Vercauteren (Invited speaker), Mathieu Fossepre (Speaker), Laurence Leherte (Speaker) & Aatto Laaksonen (Speaker)
21 Mar 2018Activity: Talk or presentation types › Invited talk
-
In vitro and in vivo models of cardiac ischemia : Past and Future
Julie Laloy (Speaker)
21 Mar 2022Activity: Talk or presentation types › Invited talk
-
Le « calibrated automated thrombogram » : une technique innovante pour mesurer la génération de thrombine.Principe, standardisation et intérêt clinique.
Jonathan Douxfils (Invited speaker)
16 Oct 2014Activity: Talk or presentation types › Invited talk
-
Le Monitoring des Nouveaux Anticoagulants Oraux
Jonathan Douxfils (Invited speaker)
27 Sept 2012Activity: Talk or presentation types › Invited talk
-
Le rôle du laboratoire dans la gestion des anticoagulants oraux directs
Jonathan Douxfils (Invited speaker)
30 Jan 2014Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Jonathan Douxfils (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Molecular dynamics simulations of cyclic ligand models interacting with protein CD58
Laurence Leherte (Invited speaker)
24 May 2019Activity: Talk or presentation types › Invited talk
-
Molecular Dynamics Simulations of Proteins using Reduced Point Charge Models
Laurence Leherte (Speaker)
30 Jan 2018Activity: Talk or presentation types › Invited talk
-
On the Intrinsic Flexibility of the μ Opioid Receptor through Multiscale Modeling Approaches
Daniel P. Vercauteren (Invited speaker)
2017 → …Activity: Talk or presentation types › Invited talk
-
Quelle place pour l'exploration biologique de l'hémostase à l'heure des NACOs?
Jonathan Douxfils (Invited speaker)
13 Jan 2014Activity: Talk or presentation types › Invited talk
-
Restoring faith in COC - An important hemostasis update
Jonathan Douxfils (Speaker)
2 Dec 2020Activity: Talk or presentation types › Invited talk
-
Réunion de Consensus INAMI/RIZIV
Jonathan Douxfils (Speaker)
30 Nov 2017Activity: Talk or presentation types › Invited talk
-
Réunion de Consensus INAMI - Prévention et traitement des thromboembolies veineuses
Jonathan Douxfils (Speaker)
21 Nov 2013Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Jonathan Douxfils (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Jonathan Douxfils (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Jonathan Douxfils (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Jonathan Douxfils (Invited speaker) & Laure Morimont (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk